{"id":202616,"date":"2024-12-13T00:00:00","date_gmt":"2024-12-13T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/47037331-medtech-heart-valve-devices-market-insights-japan\/"},"modified":"2026-03-31T10:10:36","modified_gmt":"2026-03-31T10:10:36","slug":"47042071-medtech-heart-valve-devices-market-insights-japan","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042071-medtech-heart-valve-devices-market-insights-japan\/","title":{"rendered":"Heart Valve Devices &#8211; Market Insights &#8211; Japan"},"content":{"rendered":"<p>The Japanese heart valve device market will experience modest growth, primarily driven by the increasing adoption of <abbr title=\"Transcatheter Heart Valve\">THV<\/abbr> devices. Positive clinical outcomes and the introduction of innovative products will expand the eligible patient pool, fueling <span>sustained growth<\/span> in the heart valve device market.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for heart valve devices in Japan from 2019 through 2033.<\/p>\n<p><strong>Transcatheter replacement therapies will be the driving the Japanese heart valve replacement device market.<\/strong><\/p>\n<p>Which new <abbr title=\"Transcatheter Aortic Valve Implantation \">TAVI<\/abbr> devices are poised to enter the market? What impact will these newer devices have on market dynamics and market growth?<\/p>\n<p>What new transcatheter replacement devices have been approved in the Japanese market? How will they impact the overall heart valve device market?<\/p>\n<p>When is <abbr title=\"Transcatheter Mitral Valve Implantation\">TMVI<\/abbr> therapy expected to enter the Japanese market? What <abbr title=\"Transcatheter Mitral Valve Implantation\">TMVI<\/abbr> devices are in development?<\/p>\n<p>How will <abbr title=\"Ministry of Health, Labour and Welfare\">MHLW<\/abbr> reimbursement affect <abbr title=\"Transcatheter Aortic Valve Implantation \">TAVI<\/abbr> adoption?<\/p>\n<p>How the growth in the\u00a0<abbr title=\"Transcatheter Heart Valve\">THV<\/abbr>\u00a0device market is going to impact the surgical market?<\/p>\n<p><strong>The competitive landscape for the <abbr title=\"Transcatheter Heart Valve\">THV<\/abbr> device market is evolving. <\/strong><\/p>\n<p>Which competitors have the most diverse portfolios in the heart valve device space?<\/p>\n<p class=\"question-statement\">How companies are gaining a competitive edge through mergers and acquisitions?<\/p>\n<p><strong><abbr title=\"Ministry of Health, Labour and Welfare\">MHLW<\/abbr> reimbursement revisions will affect the Japanese heart valve device market.<\/strong><\/p>\n<p>How has Japan\u2019s regulatory framework changed to align with global regulatory requirements?<\/p>\n<p>What is the impact of Japan\u2019s regulatory approval process on product launches in Japan?<\/p>\n<p>What other factors will affect <abbr title=\"Average Selling Price\">ASP<\/abbr> trends?<\/p>\n<p class=\"question-statement\"><strong>Clinical trial results play an important factor in the heart valve device market.<\/strong><\/p>\n<p>How are clinical studies and guidelines impacting the uptake of <abbr title=\"Transcatheter Heart Valve\">THV<\/abbr> devices?<\/p>\n<p>What segments have been the most impacted by clinical results?<\/p>\n<p>What will be the market impact of the approval of expanded indications for <abbr title=\"Transcatheter Aortic Valve Implantation \">TAVI<\/abbr>?<\/p>\n<p>What technologies are larger players focusing on, and how will the first-mover advantage benefit these competitors?<\/p>\n","protected":false},"template":"","class_list":["post-202616","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-heart-valve-devices","medtech-geography-japan","medtech-date-983"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/202616","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/202616\/revisions"}],"predecessor-version":[{"id":348087,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/202616\/revisions\/348087"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=202616"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}